141 related articles for article (PubMed ID: 491627)
1. Steroid levels in cancer of the prostate--markers of tumour differentiation and adequacy of anti-androgen therapy.
Geller J; Albert J; Loza D
J Steroid Biochem; 1979 Jul; 11(1B):631-6. PubMed ID: 491627
[No Abstract] [Full Text] [Related]
2. Dihydrotestosterone concentration in prostate cancer tissue as a predictor of tumor differentiation and hormonal dependency.
Geller J; Albert J; de la Vega D; Loza D; Stoeltzing W
Cancer Res; 1978 Nov; 38(11 Pt 2):4349-52. PubMed ID: 81107
[TBL] [Abstract][Full Text] [Related]
3. Total androgen suppression in the management of prostatic cancer. A critical review.
Schroeder FH
Prog Clin Biol Res; 1985; 185A():307-17. PubMed ID: 3898133
[No Abstract] [Full Text] [Related]
4. The influence of androgen deprivation therapy on dihydrotestosterone levels in the prostatic tissue of patients with prostate cancer.
Nishiyama T; Hashimoto Y; Takahashi K
Clin Cancer Res; 2004 Nov; 10(21):7121-6. PubMed ID: 15534082
[TBL] [Abstract][Full Text] [Related]
5. [Androgens].
Shida K; Ito Z; Yamanaka H
Horumon To Rinsho; 1975 Dec; 23(12):1203-19. PubMed ID: 55321
[No Abstract] [Full Text] [Related]
6. In vitro assay of androgen binding by human prostate.
Mobbs BG; Johnson IE; Connolly JG
J Steroid Biochem; 1975; 6(3-4):453-8. PubMed ID: 171495
[No Abstract] [Full Text] [Related]
7. An experimental approach to the optimum oestrogen dosage in prostatic carcinoma.
Symes EK; Milroy E
Br J Urol; 1978 Dec; 50(7):562-6. PubMed ID: 753509
[TBL] [Abstract][Full Text] [Related]
8. Redirecting abiraterone metabolism to fine-tune prostate cancer anti-androgen therapy.
Li Z; Alyamani M; Li J; Rogacki K; Abazeed M; Upadhyay SK; Balk SP; Taplin ME; Auchus RJ; Sharifi N
Nature; 2016 May; 533(7604):547-51. PubMed ID: 27225130
[TBL] [Abstract][Full Text] [Related]
9. Physiologic basis for hormonal theapy in carcinoma of the prostate.
Walsh PC
Urol Clin North Am; 1975 Feb; 2(1):125-40. PubMed ID: 48206
[No Abstract] [Full Text] [Related]
10. Stepping-stones to the further advancement of androgen-deprivation therapy for prostate cancer.
Nishiyama T; Suzuki K; Yamana K; Tonegawa E; Wako K; Takahashi K
Expert Rev Anticancer Ther; 2006 Feb; 6(2):259-68. PubMed ID: 16445378
[TBL] [Abstract][Full Text] [Related]
11. The relevance of studies on androgen action to prostatic cancer.
Mainwaring WI
Curr Top Mol Endocrinol; 1976; 4():152-71. PubMed ID: 800357
[No Abstract] [Full Text] [Related]
12. Correlation between clinical response to antiandrogenic therapy and occurrence of receptors in human prostatic cancer.
Martelli A; Grilli S; Soli M; De Giovanni C; Bercovich E; Galli MC; Prodi G
Urology; 1980 Sep; 16(3):245-9. PubMed ID: 6158782
[TBL] [Abstract][Full Text] [Related]
13. A comparative study of binding, metabolism and endogenous levels of androgens in normal, hyperplastic and carcinomatous human prostate.
Krieg M; Bartsch W; Janssen W; Voigt KD
J Steroid Biochem; 1979 Jul; 11(1B):615-24. PubMed ID: 90754
[No Abstract] [Full Text] [Related]
14. Intraprostatic testosterone and dihydrotestosterone. Part II: concentrations after androgen hormonal manipulation in men with benign prostatic hyperplasia and prostate cancer.
van der Sluis TM; Meuleman EJ; van Moorselaar RJ; Bui HN; Blankenstein MA; Heijboer AC; Vis AN
BJU Int; 2012 Jan; 109(2):183-8. PubMed ID: 21992404
[TBL] [Abstract][Full Text] [Related]
15. Prostate-specific antigen response to deferred combined androgen blockade therapy using bicalutamide predicts survival after subsequent oestrogen and docetaxel therapies in patients with castration-resistant prostate cancer.
Kijima T; Fujii Y; Yokoyama M; Ishioka J; Matsuoka Y; Numao N; Saito K; Koga F; Masuda H; Kawakami S; Kihara K
BJU Int; 2012 Oct; 110(8):1149-55. PubMed ID: 22369348
[TBL] [Abstract][Full Text] [Related]
16. [Hormonal treatment of advanced cancer of the prostate].
de Leval J
Rev Med Liege; 1991 Nov; 46(11):577-82. PubMed ID: 1754776
[No Abstract] [Full Text] [Related]
17. Female hirsutism: pathophysiological considerations and therapeutic implications.
Biffignandi P; Massucchetti C; Molinatti GM
Endocr Rev; 1984; 5(4):498-513. PubMed ID: 6094172
[No Abstract] [Full Text] [Related]
18. [Detection of androgen receptor in human prostatic carcinomas by the autoradiography].
Demura T; Sakashita S; Koyanagi T
Nihon Hinyokika Gakkai Zasshi; 1984 Sep; 75(9):1423-9. PubMed ID: 6521132
[No Abstract] [Full Text] [Related]
19. Advantages of total androgen blockade in the treatment of advanced prostate cancer.
Geller J; Albert J; Vik A
Semin Oncol; 1988 Apr; 15(2 Suppl 1):53-61. PubMed ID: 3285484
[TBL] [Abstract][Full Text] [Related]
20. Androgen Receptor Antagonists Suppress Immunotherapy in Prostate Cancer.
Cancer Discov; 2016 Jun; 6(6):569. PubMed ID: 27102077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
